Optimising influenza vaccination during a SARS-CoV-2 epidemic in South Africa could help maintain the integrity of our healthcare system.

Preiser, W; Mendelson, M; Taljaard, J

Preiser, W; Mendelson, M; Taljaard, J.

Preiser W; Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa. preiser@sun.ac.za.

S Afr Med J ; 110(4): 12873, 2020 03 17.

Article in English | MEDLINE | ID: covidwho-478839

Subject(s)

Coronavirus Infections/epidemiology; Influenza Vaccines/administration & dosage; Pneumonia, Viral/epidemiology; COVID-19; Delivery of Health Care; Humans; Pandemics; South Africa/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Influenza Vaccines / Coronavirus Infections Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: S Afr Med J Year: 2020 Document Type: Article Affiliation country: SAMJ.2020.V110I4.14692

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google